[1]
J. R. Zaveri and V. . Chaudhari, “POST MARKETING SURVEILLANCE STUDY ON RISPERIDONE IN PATIENTS SUFFERING FROM SCHIZOPHRENIA”, Natl J Med Res, vol. 1, no. 02, pp. 34–36, Dec. 2011.